SlideShare a Scribd company logo
1 of 80
Lab Testing in
Metabolic Disease:
Spotting the Red Flags, Part II
Mark Korson, MD
VMP Genetics, LLC
Disclosures
MARK KORSON does not have anything to disclose.
1. Review how simple biochemical tests
indicate important pathophysiologic
scenarios.
2. Describe patterns of routine biochemical
testing that can increase suspicion about an
underlying metabolic disease
3. Recognize the uncommon physiological
significance of certain chemistry tests
OBJECTIVES
© Copyright 2020. VMP Genetics. All rights reserved
© Copyright 2019 VMP Genetics. All rights reserved
Urinalysis - blood
An otherwise healthy athletic teenager complains
of his muscles aching after football work-outs.
He says that his arms and shoulders feel less
strong than they did during last year’s season.
After one strenuous practice (a lot of tackling), he
develops intense pain in his shoulders and upper
arms and thighs.
CASE #1
Two hours later, he voids a painless “bloody”
urine. Upon direct questioning, the color is more
cola-colored than red blood.
A urinalysis shows large blood and protein.
Case 1
• Think RENAL
BLOOD ON A URINALYSIS
© Copyright 2020. VMP Genetics. All rights reserved
U/A – blood
Micro - RBCs
• Think RENAL
BLOOD ON A URINALYSIS
U/A – blood
Micro - RBCs
U/A – blood
Micro – no RBCs
Think…
A. Heart
B. Muscle
C. Liver
D. Bladder
© Copyright 2020. VMP Genetics. All rights reserved
• Think RENAL
BLOOD ON A URINALYSIS
U/A – blood
Micro - RBCs
U/A – blood
Micro – no RBCs
Think…
A. Heart
B. Muscle
C. Liver
D. Bladder
© Copyright 2020. VMP Genetics. All rights reserved
Two hours later, he voids a painless “bloody”
urine. Upon direct questioning, the color is more
cola-colored than red blood.
A urinalysis shows large blood and protein.
Diagnosis – carnitine palmitoyltransferase (CPT) II
deficiency, a defect in fatty acid oxidation
Case 1
CARNITINE PALMITOYLTRANSFERASE (CPT) II DEF’Y
• Muscles convert fat to energy
during prolonged exercise
Physiology
© Copyright 2020. VMP Genetics. All rights reserved
• With exercise:
• Muscle pain, weakness
• Myoglobinuria
• Cardiomyopathy
Symptoms
SUMMARY POINT
• Blood on a dipstick should be confirmed
by checking for RBCs in a microscopic
examination
• If none are seen, it is not “blood”
• Think myoglobin, not hemoglobin
© Copyright 2020. VMP Genetics. All rights reserved
© Copyright 2019 VMP Genetics. All rights reserved
Transaminases
(AST, ALT)
Lab tests:
• CBC: Hgb=13.3, WBC=10.5, Plts=238
• Lytes: Na=139, K=4.5, Cl=92, HCO3=29
• BUN=10.6, creatinine=8.8
• AST=4580 (NL=5-40), ALT=1200 (NL=5-40)
• Bilirubin: Total=0.9, direct=0.1
• Alkaline phosphatase=140 (NL=44-147)
Cairns AP, et al.Nephrol Dial Transpl.2000.
Lab tests:
• CBC: Hgb=13.3, WBC=10.5, Plts=238
• Lytes: Na=139, K=4.5, Cl=92, HCO3=29
• BUN=10.6, creatinine=8.8
• AST=4580 (NL=5-40), ALT=1200 (NL=5-40)
• Bilirubin: Total=0.9, direct=0.1
• Alkaline phosphatase=140 (NL=44-147)
Cairns AP, et al.Nephrol Dial Transpl.2000.
Based on these lab
data, which organ
system worries you
the most?
A. Liver
B. Kidneys
C. Bone
D. Heart
E. Muscle
Lab tests:
• CBC: Hgb=13.3, WBC=10.5, Plts=238
• Lytes: Na=139, K=4.5, Cl=92, HCO3=29
• BUN=10.6, creatinine=8.8
• AST=4580 (NL=5-40), ALT=1200 (NL=5-40)
• Bilirubin: Total=0.9, direct=0.1
• Alkaline phosphatase=140 (NL=44-147)
Cairns AP, et al.Nephrol Dial Transpl.2000.
Based on these lab
data, which organ
system worries you
the most?
A. Liver?
B. Kidneys
C. Bone
D. Heart
E. Muscle
A 41 year old man experiences dark urine for
three days, associated with extreme fatigue, pain
and heaviness in his legs. The symptoms were
triggered after a significant amount of heavy work
while moving house the previous week.
There is a history of similar symptoms following
moderate exercise during the previous 20 years.
CASE #2
Cairns AP, et al.Nephrol Dial Transpl.2000.
Past medical history significant for two acute
episodes of gout. On no medications. Ex-smoker
(5 years). Drank ~10 units of alcohol per week.
Examination:
• HR=80/min, BP=160/82
• Normal muscle tone, power. Normal
sensation. Normal reflexes.
Cairns AP, et al.Nephrol Dial Transpl.2000.
Case 2
Lab tests:
• CBC: Hgb=13.3, WBC=10.5, Plts=238
• Lytes: Na=139, K=4.5, Cl=92, HCO3=29
• BUN=10.6, creatinine=8.8
• AST=4580 (NL=5-40), ALT=1200 (NL=5-40)
• Bilirubin: Total=0.9, direct=0.1
• Alkaline phosphatase=140 (NL=44-147)
Cairns AP, et al.Nephrol Dial Transpl.2000.
Case 2
Lab tests:
• CBC: Hgb=13.3, WBC=10.5, Plts=238
• Lytes: Na=139, K=4.5, Cl=92, HCO3=29
• BUN=10.6, creatinine=8.8
• AST=4580 (NL=5-40), ALT=1200 (NL=5-40)
• Bilirubin: Total=0.9, direct=0.1
• Alkaline phosphatase=140 (NL=44-147)
• CK=600 (NL=25-180)
• Aldolase=22.2 (NL=1.2-7.6)
Cairns AP, et al.Nephrol Dial Transpl.2000.
Case 2
Diagnosis:
• Very long chain acyl CoA dehydrogenase (VLCAD)
deficiency
Cairns AP, et al.Nephrol Dial Transpl.2000.
Case 2
VERY LONG CHAIN ACYL CoA DEHYDROGENASE (VLCAD) DEF’Y
• A defect in fatty acid oxidation
(conversion of fat to ketones)
VLCAD def’y
© Copyright 2020. VMP Genetics. All rights reserved
• The liver converts fat to ketones
during fasting or poor calorie intake
• Muscles convert fat to energy
during prolonged exercise
Physiology
VERY LONG CHAIN ACYL CoA DEHYDROGENASE (VLCAD) DEF’Y
• Reduced fasting tolerance
• Hypoglycemia, altered mental
status with prolonged fasting/poor
fat intake
• With exercise:
• Muscle pain, weakness
• Myoglobinuria
• Cardiomyopathy
Symptoms
© Copyright 2020. VMP Genetics. All rights reserved
TRANSAMINASES
• Indicators of hepatocyte integrity
• If abNL, may reflect hepatoxicity
• Abnormal in many (metabolic) diseases
Significance
© Copyright 2020. VMP Genetics. All rights reserved
TRANSAMINASES
• Indicators of hepatocyte integrity
• If abNL, may reflect hepatoxicity
• Abnormal in many (metabolic) diseases
Significance
• Concentrated in the liver but are
also found in:
• Skeletal muscle
• Myocardium
• Kidney
Not necessarily
liver-specific
© Copyright 2020. VMP Genetics. All rights reserved
A neonate is admitted to the NICU on day 3 of
life in severe congestive heart failure. On
examination, he is non-dysmorphic and
lethargic. Weight=2.2 kg.
Echocardiogram identifies a
dilated cardiomyopathy with
an ejection fraction of 20%.
CASE #3
Courtesy SIMD-NAMA 2019
Lab findings:
• Venous gas: pH=7.2, HCO3=17
• Glucose=25
• AST=230, ALT=200
• CK>500
Metabolic testing – VLCAD deficiency (a defect
in long chain fatty acid oxidation)
Courtesy SIMD-NAMA 2019
Case 3
A newborn is born at term to consanguineous
parents. Apgar score: 91 and 105. Weight=2.93
kg. On day 2, he developed lethargy and apathy.
Katz.MolecGeneticsMetabolism.2017
Lab findings:
• Glucose=normal
• AST=240, ALT=58
• CK=13,445
CASE #4
He later developed left ventricular hypertrophy
and a pericardial effusion.
Metabolic testing – VLCAD deficiency
Katz.MolecGeneticsMetabolism.2017
Case 4
SUMMARY POINT
• When AST and ALT are high, look carefully
at other markers of liver disease.
• If AST and ALT are the only ones elevated,
and/or if there are concerns about
muscle symptoms, order a CK
© Copyright 2020. VMP Genetics. All rights reserved
© Copyright 2019 VMP Genetics. All rights reserved
Bilirubin
CASE #5
A female is born to consanguineous parents (first
cousins) at term following an unremarkable
pregnancy. Normal Apgar scores. Birth
weight=3300 gm.
Develops jaundice on day 2 and starts having
feeding problems. Admitted to hospital on day 3
because of fever and jaundice. On examination,
she is lethargic and has a weak suck.
Kundak.Turk J Hemat.2012
Lab tests:
• CBC: Hgb=15.7, WBC=10.3, Plts=233
• Electrolytes: Na=147, K=4.5
• Total bilirubin=15.6, direct=1.0
• AST=1367, ALT=504
Kundak.Turk J Hemat.2012
Case 5
Lab tests:
• CBC: Hgb=15.7, WBC=10.3, Plts=233
• Electrolytes: Na=147, K=4.5
• Total bilirubin=15.6, direct=1.0
• AST=1367, ALT=504
Kundak.Turk J Hemat.2012
Case 5
Based on the nature of
the hyperbilirubinemia,
this baby is not likely to
have galactosemia.
A. True
B. False
Lab tests:
• CBC: Hgb=15.7, WBC=10.3, Plts=233
• Electrolytes: Na=147, K=4.5
• Total bilirubin=15.6, direct=1.0
• AST=1367, ALT=504
Kundak.Turk J Hemat.2012
Case 5
Based on the nature of
the hyperbilirubinemia,
this baby is not likely to
have galactosemia.
A. True
B. False
…causes a direct
hyperbilirubinemia”
“Metabolic
liver disease…
ASSESSMENT OF LIVER DISEASE / DYSFUNCTION
• …causes a direct
hyperbilirubinemia”
“Metabolic
liver disease…
ASSESSMENT OF LIVER DISEASE / DYSFUNCTION
• True but it starts as an
unconjugated hyperbilirubinemia
© Copyright 2020. VMP Genetics. All rights reserved
Age (days of life)
Direct/
Total
Bilirubin
Ratio
0 4 102 8
0.2
0.4
0.6
0.8
1.0
Galactosemia:
Direct / Total Bilirubin (n=27)
Lab tests:
• CBC: Hgb=15.7, WBC=10.3, Plts=233
• Electrolytes: Na=147, K=4.5
• Total bilirubin=15.6, direct=1.0
• AST=1367, ALT=504
• Urine reducing substances positive
Confirmation – Galactose-1-phosphate
uridyltransferase low
Diagnosis - galactosemia
Kundak.Turk J Hemat.2012
Case 5
SUMMARY POINT
• Don’t rule out a metabolic disease just
because the patient presents with
primarily an unconjugated
hyperbilirubinemia…
© Copyright 2020. VMP Genetics. All rights reserved
GALACTOSEMIA
• A defect in metabolizing galactose,
a component of milk sugar (lactose)
GALT def’y
© Copyright 2020. VMP Genetics. All rights reserved
• Poor feeding, failure to thrive
• Liver disease  failure
• Cataracts
• Sepsis risk in the newborn period
Symptoms
There is a concern for a diagnosis of
galactosemia. Cow’s milk feedings are held.
Which ONE of the following actions would be
your next move?
A. Molecular DNA testing to confirm the diagnosis
B. Complete sepsis work-up
C. Eye examination for cataracts
D. Assess for coagulopathy
CASE #6
© Copyright 2020. VMP Genetics. All rights reserved
There is a concern for a diagnosis of
galactosemia. Cow’s milk feedings are held.
Which ONE of the following actions would be
your next move?
A. Molecular DNA testing to confirm the diagnosis
B. Complete sepsis work-up
C. Eye examination for cataracts
D. Assess for coagulopathy
© Copyright 2020. VMP Genetics. All rights reserved
Case 6
Lab tests:
• CBC: Hgb=15.7, WBC=10.3, Plts=233
• Electrolytes: Na=147, K=4.5
• Total bilirubin=15.6, direct=1.0
• AST=1367, ALT=504
• Urine reducing substances positive
• PT>60 sec; INR>6; aPTT=88 sec
Diagnosis – classical galactosemia Kundak.Turk J Hemat.2012
Case 6
COAGULATION MEASUREMENTS
• An important indicator of
hepatic synthetic function
Significance
• Transaminase and bilirubin levels
do not predict and do not
correlate with PT, INR, PTT
Caution!
© Copyright 2020. VMP Genetics. All rights reserved
A male infant presents with lethargy. His belly is
distended due to ascites and his liver edge is
irregular and firm at 5 cm below the right costal
margin.
• AST=65
• Bilirubin: total=2.1, direct=0.99
• PT=26.8 sec, INR=61.1 sec
Case #7 - TYROSINEMIA TYPE I
Rashad.SudJPediatr.2011
REMINDER
• When assessing a patient for possible
metabolic liver disease, always assess all
aspects of liver function.
© Copyright 2020. VMP Genetics. All rights reserved
• AST, ALT
• Alkaline phosphatase
(5’-nucleotidase and GGTP)
• Bilirubin, total and direct
• PT, INR, PTT
• Albumin
Tests
ASSESSMENT OF LIVER DISEASE / DYSFUNCTION
© Copyright 2020. VMP Genetics. All rights reserved
• AST, ALT
• Alkaline phosphatase
(5’-nucleotidase and GGTP)
• Bilirubin, total and direct
• PT, INR, PTT
• Albumin
• ⍺-fetoprotein
• Glucose, NH3
Tests
ASSESSMENT OF LIVER DISEASE / DYSFUNCTION
© Copyright 2020. VMP Genetics. All rights reserved
© Copyright 2019 VMP Genetics. All rights reserved
The anion gap (electrolytes)
Urinalysis - pH
What is the most common cause
of a metabolic acidosis?
© Copyright 2020. VMP Genetics. All rights reserved
PRIMARY METABOLIC
ACIDOSIS
INCREASED ANION GAP NORMAL ANION GAP
- GI disease
© Copyright 2020. VMP Genetics. All rights reserved
PRIMARY METABOLIC
ACIDOSIS
INCREASED ANION GAP NORMAL ANION GAP
- GI disease
- Renal disease
- Metabolic disease
© Copyright 2020. VMP Genetics. All rights reserved
PRIMARY METABOLIC
ACIDOSIS
INCREASED ANION GAP NORMAL ANION GAP
- GI disease
- Renal disease
- Metabolic disease
- Shock, dehydration
- Starvation
- Poisons, toxins
- Metabolic disease
© Copyright 2020. VMP Genetics. All rights reserved
PRIMARY METABOLIC
ACIDOSIS
INCREASED ANION GAPINCREASED ANION GAP
- Shock, dehydration
- Starvation
- Poisons, toxins
- Metabolic disease
ORGANIC ACIDEMIAS
CONGENITAL LACTIC ACIDEMIAS
© Copyright 2020. VMP Genetics. All rights reserved
PRIMARY METABOLIC
ACIDOSIS
NORMAL ANION GAP
- GI disease
- Renal disease
- Metabolic disease
METABOLIC LIVER DISEASE
MITOCHONDRIAL DISEASE
CYSTINOSIS
© Copyright 2020. VMP Genetics. All rights reserved
THE “ANION GAP”
There is no “anion gap” really…
© Copyright 2020. VMP Genetics. All rights reserved
THE ANION GAP
• Difference between measured
anions and cations in the blood
Definition
Calculation • Anion gap = Na - (Cl + HCO3)
• Anion gap = 140 - (105 + 25)
• Anion gap = 10
• Normal anion gap = 10-15
© Copyright 2020. VMP Genetics. All rights reserved
THE NON-ANION GAP ACIDOSIS
Anion gap = Na - (Cl + HCO3)
Anion gap = 140 - (115 + 10)
Anion gap = 15
HIGH
NORMAL
LOW
 Bicarbonate loss (urine or stool)
© Copyright 2020. VMP Genetics. All rights reserved
THE ANION GAP ACIDOSIS
Anion gap = Na - (Cl + HCO3)
Anion gap = 140 - (105 + 10)
Anion gap = 25
NORMAL
HIGH
LOW
 Anion accumulation
© Copyright 2020. VMP Genetics. All rights reserved
THE ANION GAP ACIDOSIS
Anion gap = Na - (Cl + HCO3)
Anion gap = 140 - (105 + 10)
Anion gap = 25
 Anion accumulation
(lactate, ketones, organic acids,
toxins…)
NORMAL
HIGH
LOW
© Copyright 2020. VMP Genetics. All rights reserved
A 6 month old infant male, product of a healthy
pregnancy/labor/delivery, is found to have a
distended belly at 3 months. By that time, he has
lost 1 kg of weight and is failing to thrive. He
continues to feed every 3-4 hours day and night.
At 5 months of age, the liver is noted to be
enlarged. He is evaluated in the ED shortly after
that for fever and upper respiratory symptoms.
He presents to the ED, looking ill. Last feeding
~3 hours prior to arrival.
CASE #8
© Copyright 2020. VMP Genetics. All rights reserved
Lab tests:
• Glucose=39 mg/dL
• Electrolytes: Na=141, K=3.7, Cl=112,
HCO3=15
• ALT=118, AST=274
• Other liver functions normal
• Lactate=3.6 mmol/L (NL<2.2)
• Urinalysis: pH=6.5
© Copyright 2020. VMP Genetics. All rights reserved
Case 8
Lab tests:
• Glucose=39 mg/dL
• Electrolytes: Na=141, K=3.7, Cl=112,
HCO3=15
• ALT=118, AST=274
• Other liver functions normal
• Lactate=3.6 mmol/L (NL<2.2)
• Urinalysis: pH=6.5
© Copyright 2020. VMP Genetics. All rights reserved
Anion gap = 14 (NL)
Case 8
Lab tests:
• Glucose=39 mg/dL
• Electrolytes: Na=141, K=3.7, Cl=112,
HCO3=15
• ALT=118, AST=274
• Other liver functions normal
• Lactate=3.6 mmol/L (NL<2.2)
• Urinalysis: pH=6.5
Based on these
clinical/lab data, this
patient has liver disease.
Which other organ are
you worried about?
A. Brain
B. Kidneys
C. Eyes
D. Heart
E. Muscle
© Copyright 2020. VMP Genetics. All rights reserved
Case 8
Lab tests:
• Glucose=39 mg/dL
• Electrolytes: Na=141, K=3.7, Cl=112,
HCO3=15
• ALT=118, AST=274
• Other liver functions normal
• Lactate=3.6 mmol/L (NL<2.2)
• Urinalysis: pH=6.5
Based on these
clinical/lab data, this
patient has liver disease.
Which other organ are
you worried about?
A. Brain
B. Kidneys
C. Eyes
D. Heart
E. Muscle
© Copyright 2020. VMP Genetics. All rights reserved
Case 8
Lab tests:
• Glucose=39 mg/dL
• Electrolytes: Na=141, K=3.7, Cl=112,
HCO3=15
• ALT=118, AST=274
• Other liver functions normal
• Lactate=3.6 mmol/L (NL<2.2)
• Urinalysis: pH=6.5
Diagnosis – glycogen storage
disease type I
Based on these
clinical/lab data, this
patient has liver disease.
Which other organ are
you worried about?
A. Brain
B. Kidneys
C. Eyes
D. Heart
E. Muscle
© Copyright 2020. VMP Genetics. All rights reserved
Case 8
© Copyright 2019 VMP Genetics. All rights reserved
Glucose + Ketones
Three glucose-ketone scenarios:
A. The septic newborn:
• Blood glucose=32 mg/dL
• Urine ketones=trace
B. The 3 month old child with
gastroenteritis and dehydration:
• Blood glucose=40 mg/dL
• Urine ketones=1+
C. The septic newborn:
• Blood glucose=32 mg/dL
• Urine ketones=4+
CASE #9
© Copyright 2020. VMP Genetics. All rights reserved
All are abnormal clinical
situations but which of
the glucose-ketone
relationships are
pathological?
A. A, B, C
B. A, B
C. B, C
D. A, C
E. A
HYPOKETOTIC HYPOGLYCEMIA
© Copyright 2020. VMP Genetics. All rights reserved
HYPOKETOTIC HYPOGLYCEMIA
HIGH Insulin
State
LOW Insulin
State
© Copyright 2020. VMP Genetics. All rights reserved
HYPOKETOTIC HYPOGLYCEMIA
HIGH Insulin
State
FAT FATTY
ACIDS
KETONES
© Copyright 2020. VMP Genetics. All rights reserved
HYPOKETOTIC HYPOGLYCEMIA
HIGH Insulin
State
• Insulin tumor
• Infant of DM mother
• Beckwith-Wiedemann
syndrome
• Iatrogenic
© Copyright 2020. VMP Genetics. All rights reserved
HYPOKETOTIC HYPOGLYCEMIA
FAT FATTY
ACIDS
KETONES
LOW Insulin
State
© Copyright 2020. VMP Genetics. All rights reserved
HYPOKETOTIC HYPOGLYCEMIA
LOW Insulin
State
• Fatty acid oxidation
defects
• Glycogen storage disease
type I
© Copyright 2020. VMP Genetics. All rights reserved
• Immaturity in fatty acid
oxidation  reduced
production
• Rapid metabolic rates 
increased
consumption/uptake
• …hypoketotic hypoglycemia
is normal
In neonates…
WHAT’S THE STORY WITH NEONATAL KETOGENESIS?
© Copyright 2020. VMP Genetics. All rights reserved
• Hypoketosis is normal
• Significant ketosis is not
normal
• Absent or inadequate ketosis
is never normal in a very
catabolic or hypoglycemic
child
In neonates…
KETONES – “THE RULES”
Beyond 2-3
months of age…
© Copyright 2020. VMP Genetics. All rights reserved
Three glucose-ketone scenarios:
A. The septic newborn:
• Blood glucose=32 mg/dL
• Urine ketones=trace
B. The 3 month old child with
gastroenteritis and dehydration:
• Blood glucose=40 mg/dL
• Urine ketones=1+
C. The septic newborn:
• Blood glucose=32 mg/dL
• Urine ketones=4+
CASE #9
© Copyright 2020. VMP Genetics. All rights reserved
All are abnormal clinical
situations but which of
the glucose-ketone
relationships are
pathological?
A. A, B, C
B. A, B
C. B, C
D. A, C
E. A
Three glucose-ketone scenarios:
A. The septic newborn:
• Blood glucose=32 mg/dL
• Urine ketones=trace
B. The 3 month old child with
gastroenteritis and dehydration:
• Blood glucose=40 mg/dL
• Urine ketones=1+
C. The septic newborn:
• Blood glucose=32 mg/dL
• Urine ketones=4+
CASE #9
© Copyright 2020. VMP Genetics. All rights reserved
All are abnormal clinical
situations but which of
the glucose-ketone
relationships are
pathological?
A. A, B, C
B. A, B
C. B, C
D. A, C
E. A
Questions?
Call Genetics!
We like answering your questions!
THANK YOU FOR
PARTICIPATING TODAY.

More Related Content

What's hot

A revision and quiz on heme synthesis and degradation
A revision and quiz on heme synthesis and degradationA revision and quiz on heme synthesis and degradation
A revision and quiz on heme synthesis and degradationNamrata Chhabra
 
Antiphospholipid antibody syndrome
Antiphospholipid antibody syndromeAntiphospholipid antibody syndrome
Antiphospholipid antibody syndromeshiv lasune
 
A kliewer case_2_doc
A kliewer case_2_docA kliewer case_2_doc
A kliewer case_2_docakliewer
 
Renal diseases; CK lecture notes & step up to medicine
Renal diseases; CK lecture notes & step up to medicineRenal diseases; CK lecture notes & step up to medicine
Renal diseases; CK lecture notes & step up to medicineMays Yousuf
 

What's hot (7)

A revision and quiz on heme synthesis and degradation
A revision and quiz on heme synthesis and degradationA revision and quiz on heme synthesis and degradation
A revision and quiz on heme synthesis and degradation
 
G 1 貧血3 巨赤芽球性
G 1 貧血3 巨赤芽球性G 1 貧血3 巨赤芽球性
G 1 貧血3 巨赤芽球性
 
Antiphospholipid antibody syndrome
Antiphospholipid antibody syndromeAntiphospholipid antibody syndrome
Antiphospholipid antibody syndrome
 
A kliewer case_2_doc
A kliewer case_2_docA kliewer case_2_doc
A kliewer case_2_doc
 
Renal diseases; CK lecture notes & step up to medicine
Renal diseases; CK lecture notes & step up to medicineRenal diseases; CK lecture notes & step up to medicine
Renal diseases; CK lecture notes & step up to medicine
 
2007
20072007
2007
 
Julia Wendon - Evidence base - IFAD 2011
Julia Wendon - Evidence base - IFAD 2011Julia Wendon - Evidence base - IFAD 2011
Julia Wendon - Evidence base - IFAD 2011
 

Similar to Red Flags Part II

ARF No ATN Data
ARF No ATN DataARF No ATN Data
ARF No ATN DataJoel Topf
 
Interpretation of Clinical Laboratory Tests
Interpretation of Clinical Laboratory TestsInterpretation of Clinical Laboratory Tests
Interpretation of Clinical Laboratory Testssunayanamali
 
Dose Adjustment in Renal Failure ...Practical Approach for Clinical Pharmacists
Dose Adjustment in Renal Failure ...Practical Approach for Clinical PharmacistsDose Adjustment in Renal Failure ...Practical Approach for Clinical Pharmacists
Dose Adjustment in Renal Failure ...Practical Approach for Clinical PharmacistsKareem El-Fass BPharm,PharmD
 
Chronic Kidney Disease, CKD, Nephrology,
Chronic Kidney Disease, CKD, Nephrology, Chronic Kidney Disease, CKD, Nephrology,
Chronic Kidney Disease, CKD, Nephrology, Dee Evardone
 
高雄地區第492次小兒科聯合病例討論會
高雄地區第492次小兒科聯合病例討論會高雄地區第492次小兒科聯合病例討論會
高雄地區第492次小兒科聯合病例討論會Ks doctor
 
Non alcoholic fatty liver disease
Non alcoholic fatty liver diseaseNon alcoholic fatty liver disease
Non alcoholic fatty liver diseaseakifab93
 
Spots for Biochemistry
Spots for Biochemistry Spots for Biochemistry
Spots for Biochemistry RAJNKIT
 
BIOCHEMISTRY II EXAM ANSWERS
BIOCHEMISTRY II EXAM ANSWERSBIOCHEMISTRY II EXAM ANSWERS
BIOCHEMISTRY II EXAM ANSWERSMUBOSScz
 
Overview of acute kidney injury (AKI)
Overview of acute kidney injury (AKI)Overview of acute kidney injury (AKI)
Overview of acute kidney injury (AKI)Dr. SAQUIB SIDDIQUI
 
Diabetic keto acidosis
Diabetic keto acidosisDiabetic keto acidosis
Diabetic keto acidosisKumar Abhinav
 
DIABETIC KETOACIDOSIS IN ER
DIABETIC KETOACIDOSIS IN ERDIABETIC KETOACIDOSIS IN ER
DIABETIC KETOACIDOSIS IN ERIsmat Alborhan
 

Similar to Red Flags Part II (20)

Nephrology Board Review
Nephrology Board ReviewNephrology Board Review
Nephrology Board Review
 
DKA in children
DKA in childrenDKA in children
DKA in children
 
ABG3 Series
ABG3  SeriesABG3  Series
ABG3 Series
 
ABG5 Series
ABG5  SeriesABG5  Series
ABG5 Series
 
ARF No ATN Data
ARF No ATN DataARF No ATN Data
ARF No ATN Data
 
Interpretation of Clinical Laboratory Tests
Interpretation of Clinical Laboratory TestsInterpretation of Clinical Laboratory Tests
Interpretation of Clinical Laboratory Tests
 
Dose Adjustment in Renal Failure ...Practical Approach for Clinical Pharmacists
Dose Adjustment in Renal Failure ...Practical Approach for Clinical PharmacistsDose Adjustment in Renal Failure ...Practical Approach for Clinical Pharmacists
Dose Adjustment in Renal Failure ...Practical Approach for Clinical Pharmacists
 
RPGN.pptx
RPGN.pptxRPGN.pptx
RPGN.pptx
 
Chronic Kidney Disease, CKD, Nephrology,
Chronic Kidney Disease, CKD, Nephrology, Chronic Kidney Disease, CKD, Nephrology,
Chronic Kidney Disease, CKD, Nephrology,
 
高雄地區第492次小兒科聯合病例討論會
高雄地區第492次小兒科聯合病例討論會高雄地區第492次小兒科聯合病例討論會
高雄地區第492次小兒科聯合病例討論會
 
Acid base disorders
Acid base disordersAcid base disorders
Acid base disorders
 
Non alcoholic fatty liver disease
Non alcoholic fatty liver diseaseNon alcoholic fatty liver disease
Non alcoholic fatty liver disease
 
Spots for Biochemistry
Spots for Biochemistry Spots for Biochemistry
Spots for Biochemistry
 
BIOCHEMISTRY II EXAM ANSWERS
BIOCHEMISTRY II EXAM ANSWERSBIOCHEMISTRY II EXAM ANSWERS
BIOCHEMISTRY II EXAM ANSWERS
 
Overview of acute kidney injury (AKI)
Overview of acute kidney injury (AKI)Overview of acute kidney injury (AKI)
Overview of acute kidney injury (AKI)
 
Diabetic keto acidosis
Diabetic keto acidosisDiabetic keto acidosis
Diabetic keto acidosis
 
Dr Rajkumar
Dr Rajkumar Dr Rajkumar
Dr Rajkumar
 
Cardiac function tests.pptx
Cardiac function tests.pptxCardiac function tests.pptx
Cardiac function tests.pptx
 
Interesting Case of Rowells syndrome
Interesting Case of Rowells syndromeInteresting Case of Rowells syndrome
Interesting Case of Rowells syndrome
 
DIABETIC KETOACIDOSIS IN ER
DIABETIC KETOACIDOSIS IN ERDIABETIC KETOACIDOSIS IN ER
DIABETIC KETOACIDOSIS IN ER
 

More from CHC Connecticut

Re-engaging Patients in Dental Care
Re-engaging Patients in Dental CareRe-engaging Patients in Dental Care
Re-engaging Patients in Dental CareCHC Connecticut
 
NTTAP Webinar Series - June 7, 2023: Integrating HIV Care into Training and E...
NTTAP Webinar Series - June 7, 2023: Integrating HIV Care into Training and E...NTTAP Webinar Series - June 7, 2023: Integrating HIV Care into Training and E...
NTTAP Webinar Series - June 7, 2023: Integrating HIV Care into Training and E...CHC Connecticut
 
Utilizing the Readiness to Train Assessment Tool (RTAT™) To Assess Your Capac...
Utilizing the Readiness to Train Assessment Tool (RTAT™) To Assess Your Capac...Utilizing the Readiness to Train Assessment Tool (RTAT™) To Assess Your Capac...
Utilizing the Readiness to Train Assessment Tool (RTAT™) To Assess Your Capac...CHC Connecticut
 
NTTAP Webinar Series - May 18, 2023: The Changing Landscape of Behavioral Hea...
NTTAP Webinar Series - May 18, 2023: The Changing Landscape of Behavioral Hea...NTTAP Webinar Series - May 18, 2023: The Changing Landscape of Behavioral Hea...
NTTAP Webinar Series - May 18, 2023: The Changing Landscape of Behavioral Hea...CHC Connecticut
 
Newborn Screening - May 9, 2023
Newborn Screening - May 9, 2023Newborn Screening - May 9, 2023
Newborn Screening - May 9, 2023CHC Connecticut
 
Health Professions Student Training Webinar: Assessing Organizational Capacity
Health Professions Student Training Webinar: Assessing Organizational CapacityHealth Professions Student Training Webinar: Assessing Organizational Capacity
Health Professions Student Training Webinar: Assessing Organizational CapacityCHC Connecticut
 
Training the Next Generation: Investing in Workforce Training
Training the Next Generation: Investing in Workforce TrainingTraining the Next Generation: Investing in Workforce Training
Training the Next Generation: Investing in Workforce TrainingCHC Connecticut
 
NTTAP Webinar Series - April 13, 2023: Quality Improvement Strategies in a Te...
NTTAP Webinar Series - April 13, 2023: Quality Improvement Strategies in a Te...NTTAP Webinar Series - April 13, 2023: Quality Improvement Strategies in a Te...
NTTAP Webinar Series - April 13, 2023: Quality Improvement Strategies in a Te...CHC Connecticut
 
Addressing Genetics Workforce Shortage - April 11, 2023
Addressing Genetics Workforce Shortage - April 11, 2023Addressing Genetics Workforce Shortage - April 11, 2023
Addressing Genetics Workforce Shortage - April 11, 2023CHC Connecticut
 
Implementation of Timely and Effective Transitional Care Management Processes
Implementation of Timely and Effective Transitional Care Management ProcessesImplementation of Timely and Effective Transitional Care Management Processes
Implementation of Timely and Effective Transitional Care Management ProcessesCHC Connecticut
 
Direct to Consumer Test and Ancestry Testing - March 14, 2023
Direct to Consumer Test and Ancestry Testing - March 14, 2023Direct to Consumer Test and Ancestry Testing - March 14, 2023
Direct to Consumer Test and Ancestry Testing - March 14, 2023CHC Connecticut
 
Implement Behavioral Health Training Programs to Address a Crucial National S...
Implement Behavioral Health Training Programs to Address a Crucial National S...Implement Behavioral Health Training Programs to Address a Crucial National S...
Implement Behavioral Health Training Programs to Address a Crucial National S...CHC Connecticut
 
Genetic Connections to Breast Cancer - February 14, 2023
Genetic Connections to Breast Cancer - February 14, 2023Genetic Connections to Breast Cancer - February 14, 2023
Genetic Connections to Breast Cancer - February 14, 2023CHC Connecticut
 
Connective Tissue Disorders Slides - January 17, 2023
Connective Tissue Disorders Slides - January 17, 2023Connective Tissue Disorders Slides - January 17, 2023
Connective Tissue Disorders Slides - January 17, 2023CHC Connecticut
 
Implementation of Facial Recognition Software for Clinical Genetics Practice...
 Implementation of Facial Recognition Software for Clinical Genetics Practice... Implementation of Facial Recognition Software for Clinical Genetics Practice...
Implementation of Facial Recognition Software for Clinical Genetics Practice...CHC Connecticut
 
HIV Prevention: Combating PrEP Implementation Challenges
HIV Prevention: Combating PrEP Implementation ChallengesHIV Prevention: Combating PrEP Implementation Challenges
HIV Prevention: Combating PrEP Implementation ChallengesCHC Connecticut
 
NTTAP Webinar Series - December 7, 2022: Advancing Team-Based Care: Enhancing...
NTTAP Webinar Series - December 7, 2022: Advancing Team-Based Care: Enhancing...NTTAP Webinar Series - December 7, 2022: Advancing Team-Based Care: Enhancing...
NTTAP Webinar Series - December 7, 2022: Advancing Team-Based Care: Enhancing...CHC Connecticut
 
Genetics Cases and Resources Webinar Slides - November 8, 2022
Genetics Cases and Resources Webinar Slides - November 8, 2022Genetics Cases and Resources Webinar Slides - November 8, 2022
Genetics Cases and Resources Webinar Slides - November 8, 2022CHC Connecticut
 
NTTAP Webinar: Postgraduate NP/PA Residency: Discussing your Key Program Staf...
NTTAP Webinar: Postgraduate NP/PA Residency: Discussing your Key Program Staf...NTTAP Webinar: Postgraduate NP/PA Residency: Discussing your Key Program Staf...
NTTAP Webinar: Postgraduate NP/PA Residency: Discussing your Key Program Staf...CHC Connecticut
 
Training the Next Generation within Primary Care
Training the Next Generation within Primary CareTraining the Next Generation within Primary Care
Training the Next Generation within Primary CareCHC Connecticut
 

More from CHC Connecticut (20)

Re-engaging Patients in Dental Care
Re-engaging Patients in Dental CareRe-engaging Patients in Dental Care
Re-engaging Patients in Dental Care
 
NTTAP Webinar Series - June 7, 2023: Integrating HIV Care into Training and E...
NTTAP Webinar Series - June 7, 2023: Integrating HIV Care into Training and E...NTTAP Webinar Series - June 7, 2023: Integrating HIV Care into Training and E...
NTTAP Webinar Series - June 7, 2023: Integrating HIV Care into Training and E...
 
Utilizing the Readiness to Train Assessment Tool (RTAT™) To Assess Your Capac...
Utilizing the Readiness to Train Assessment Tool (RTAT™) To Assess Your Capac...Utilizing the Readiness to Train Assessment Tool (RTAT™) To Assess Your Capac...
Utilizing the Readiness to Train Assessment Tool (RTAT™) To Assess Your Capac...
 
NTTAP Webinar Series - May 18, 2023: The Changing Landscape of Behavioral Hea...
NTTAP Webinar Series - May 18, 2023: The Changing Landscape of Behavioral Hea...NTTAP Webinar Series - May 18, 2023: The Changing Landscape of Behavioral Hea...
NTTAP Webinar Series - May 18, 2023: The Changing Landscape of Behavioral Hea...
 
Newborn Screening - May 9, 2023
Newborn Screening - May 9, 2023Newborn Screening - May 9, 2023
Newborn Screening - May 9, 2023
 
Health Professions Student Training Webinar: Assessing Organizational Capacity
Health Professions Student Training Webinar: Assessing Organizational CapacityHealth Professions Student Training Webinar: Assessing Organizational Capacity
Health Professions Student Training Webinar: Assessing Organizational Capacity
 
Training the Next Generation: Investing in Workforce Training
Training the Next Generation: Investing in Workforce TrainingTraining the Next Generation: Investing in Workforce Training
Training the Next Generation: Investing in Workforce Training
 
NTTAP Webinar Series - April 13, 2023: Quality Improvement Strategies in a Te...
NTTAP Webinar Series - April 13, 2023: Quality Improvement Strategies in a Te...NTTAP Webinar Series - April 13, 2023: Quality Improvement Strategies in a Te...
NTTAP Webinar Series - April 13, 2023: Quality Improvement Strategies in a Te...
 
Addressing Genetics Workforce Shortage - April 11, 2023
Addressing Genetics Workforce Shortage - April 11, 2023Addressing Genetics Workforce Shortage - April 11, 2023
Addressing Genetics Workforce Shortage - April 11, 2023
 
Implementation of Timely and Effective Transitional Care Management Processes
Implementation of Timely and Effective Transitional Care Management ProcessesImplementation of Timely and Effective Transitional Care Management Processes
Implementation of Timely and Effective Transitional Care Management Processes
 
Direct to Consumer Test and Ancestry Testing - March 14, 2023
Direct to Consumer Test and Ancestry Testing - March 14, 2023Direct to Consumer Test and Ancestry Testing - March 14, 2023
Direct to Consumer Test and Ancestry Testing - March 14, 2023
 
Implement Behavioral Health Training Programs to Address a Crucial National S...
Implement Behavioral Health Training Programs to Address a Crucial National S...Implement Behavioral Health Training Programs to Address a Crucial National S...
Implement Behavioral Health Training Programs to Address a Crucial National S...
 
Genetic Connections to Breast Cancer - February 14, 2023
Genetic Connections to Breast Cancer - February 14, 2023Genetic Connections to Breast Cancer - February 14, 2023
Genetic Connections to Breast Cancer - February 14, 2023
 
Connective Tissue Disorders Slides - January 17, 2023
Connective Tissue Disorders Slides - January 17, 2023Connective Tissue Disorders Slides - January 17, 2023
Connective Tissue Disorders Slides - January 17, 2023
 
Implementation of Facial Recognition Software for Clinical Genetics Practice...
 Implementation of Facial Recognition Software for Clinical Genetics Practice... Implementation of Facial Recognition Software for Clinical Genetics Practice...
Implementation of Facial Recognition Software for Clinical Genetics Practice...
 
HIV Prevention: Combating PrEP Implementation Challenges
HIV Prevention: Combating PrEP Implementation ChallengesHIV Prevention: Combating PrEP Implementation Challenges
HIV Prevention: Combating PrEP Implementation Challenges
 
NTTAP Webinar Series - December 7, 2022: Advancing Team-Based Care: Enhancing...
NTTAP Webinar Series - December 7, 2022: Advancing Team-Based Care: Enhancing...NTTAP Webinar Series - December 7, 2022: Advancing Team-Based Care: Enhancing...
NTTAP Webinar Series - December 7, 2022: Advancing Team-Based Care: Enhancing...
 
Genetics Cases and Resources Webinar Slides - November 8, 2022
Genetics Cases and Resources Webinar Slides - November 8, 2022Genetics Cases and Resources Webinar Slides - November 8, 2022
Genetics Cases and Resources Webinar Slides - November 8, 2022
 
NTTAP Webinar: Postgraduate NP/PA Residency: Discussing your Key Program Staf...
NTTAP Webinar: Postgraduate NP/PA Residency: Discussing your Key Program Staf...NTTAP Webinar: Postgraduate NP/PA Residency: Discussing your Key Program Staf...
NTTAP Webinar: Postgraduate NP/PA Residency: Discussing your Key Program Staf...
 
Training the Next Generation within Primary Care
Training the Next Generation within Primary CareTraining the Next Generation within Primary Care
Training the Next Generation within Primary Care
 

Recently uploaded

Textual Evidence in Reading and Writing of SHS
Textual Evidence in Reading and Writing of SHSTextual Evidence in Reading and Writing of SHS
Textual Evidence in Reading and Writing of SHSMae Pangan
 
Q-Factor General Quiz-7th April 2024, Quiz Club NITW
Q-Factor General Quiz-7th April 2024, Quiz Club NITWQ-Factor General Quiz-7th April 2024, Quiz Club NITW
Q-Factor General Quiz-7th April 2024, Quiz Club NITWQuiz Club NITW
 
Concurrency Control in Database Management system
Concurrency Control in Database Management systemConcurrency Control in Database Management system
Concurrency Control in Database Management systemChristalin Nelson
 
4.16.24 Poverty and Precarity--Desmond.pptx
4.16.24 Poverty and Precarity--Desmond.pptx4.16.24 Poverty and Precarity--Desmond.pptx
4.16.24 Poverty and Precarity--Desmond.pptxmary850239
 
DIFFERENT BASKETRY IN THE PHILIPPINES PPT.pptx
DIFFERENT BASKETRY IN THE PHILIPPINES PPT.pptxDIFFERENT BASKETRY IN THE PHILIPPINES PPT.pptx
DIFFERENT BASKETRY IN THE PHILIPPINES PPT.pptxMichelleTuguinay1
 
Measures of Position DECILES for ungrouped data
Measures of Position DECILES for ungrouped dataMeasures of Position DECILES for ungrouped data
Measures of Position DECILES for ungrouped dataBabyAnnMotar
 
Using Grammatical Signals Suitable to Patterns of Idea Development
Using Grammatical Signals Suitable to Patterns of Idea DevelopmentUsing Grammatical Signals Suitable to Patterns of Idea Development
Using Grammatical Signals Suitable to Patterns of Idea Developmentchesterberbo7
 
Expanded definition: technical and operational
Expanded definition: technical and operationalExpanded definition: technical and operational
Expanded definition: technical and operationalssuser3e220a
 
Reading and Writing Skills 11 quarter 4 melc 1
Reading and Writing Skills 11 quarter 4 melc 1Reading and Writing Skills 11 quarter 4 melc 1
Reading and Writing Skills 11 quarter 4 melc 1GloryAnnCastre1
 
Student Profile Sample - We help schools to connect the data they have, with ...
Student Profile Sample - We help schools to connect the data they have, with ...Student Profile Sample - We help schools to connect the data they have, with ...
Student Profile Sample - We help schools to connect the data they have, with ...Seán Kennedy
 
Decoding the Tweet _ Practical Criticism in the Age of Hashtag.pptx
Decoding the Tweet _ Practical Criticism in the Age of Hashtag.pptxDecoding the Tweet _ Practical Criticism in the Age of Hashtag.pptx
Decoding the Tweet _ Practical Criticism in the Age of Hashtag.pptxDhatriParmar
 
How to Fix XML SyntaxError in Odoo the 17
How to Fix XML SyntaxError in Odoo the 17How to Fix XML SyntaxError in Odoo the 17
How to Fix XML SyntaxError in Odoo the 17Celine George
 
ICS2208 Lecture6 Notes for SL spaces.pdf
ICS2208 Lecture6 Notes for SL spaces.pdfICS2208 Lecture6 Notes for SL spaces.pdf
ICS2208 Lecture6 Notes for SL spaces.pdfVanessa Camilleri
 
Narcotic and Non Narcotic Analgesic..pdf
Narcotic and Non Narcotic Analgesic..pdfNarcotic and Non Narcotic Analgesic..pdf
Narcotic and Non Narcotic Analgesic..pdfPrerana Jadhav
 
INTRODUCTION TO CATHOLIC CHRISTOLOGY.pptx
INTRODUCTION TO CATHOLIC CHRISTOLOGY.pptxINTRODUCTION TO CATHOLIC CHRISTOLOGY.pptx
INTRODUCTION TO CATHOLIC CHRISTOLOGY.pptxHumphrey A Beña
 
Beauty Amidst the Bytes_ Unearthing Unexpected Advantages of the Digital Wast...
Beauty Amidst the Bytes_ Unearthing Unexpected Advantages of the Digital Wast...Beauty Amidst the Bytes_ Unearthing Unexpected Advantages of the Digital Wast...
Beauty Amidst the Bytes_ Unearthing Unexpected Advantages of the Digital Wast...DhatriParmar
 
Q-Factor HISPOL Quiz-6th April 2024, Quiz Club NITW
Q-Factor HISPOL Quiz-6th April 2024, Quiz Club NITWQ-Factor HISPOL Quiz-6th April 2024, Quiz Club NITW
Q-Factor HISPOL Quiz-6th April 2024, Quiz Club NITWQuiz Club NITW
 

Recently uploaded (20)

Mattingly "AI & Prompt Design: Large Language Models"
Mattingly "AI & Prompt Design: Large Language Models"Mattingly "AI & Prompt Design: Large Language Models"
Mattingly "AI & Prompt Design: Large Language Models"
 
prashanth updated resume 2024 for Teaching Profession
prashanth updated resume 2024 for Teaching Professionprashanth updated resume 2024 for Teaching Profession
prashanth updated resume 2024 for Teaching Profession
 
Textual Evidence in Reading and Writing of SHS
Textual Evidence in Reading and Writing of SHSTextual Evidence in Reading and Writing of SHS
Textual Evidence in Reading and Writing of SHS
 
Q-Factor General Quiz-7th April 2024, Quiz Club NITW
Q-Factor General Quiz-7th April 2024, Quiz Club NITWQ-Factor General Quiz-7th April 2024, Quiz Club NITW
Q-Factor General Quiz-7th April 2024, Quiz Club NITW
 
Concurrency Control in Database Management system
Concurrency Control in Database Management systemConcurrency Control in Database Management system
Concurrency Control in Database Management system
 
4.16.24 Poverty and Precarity--Desmond.pptx
4.16.24 Poverty and Precarity--Desmond.pptx4.16.24 Poverty and Precarity--Desmond.pptx
4.16.24 Poverty and Precarity--Desmond.pptx
 
DIFFERENT BASKETRY IN THE PHILIPPINES PPT.pptx
DIFFERENT BASKETRY IN THE PHILIPPINES PPT.pptxDIFFERENT BASKETRY IN THE PHILIPPINES PPT.pptx
DIFFERENT BASKETRY IN THE PHILIPPINES PPT.pptx
 
Paradigm shift in nursing research by RS MEHTA
Paradigm shift in nursing research by RS MEHTAParadigm shift in nursing research by RS MEHTA
Paradigm shift in nursing research by RS MEHTA
 
Measures of Position DECILES for ungrouped data
Measures of Position DECILES for ungrouped dataMeasures of Position DECILES for ungrouped data
Measures of Position DECILES for ungrouped data
 
Using Grammatical Signals Suitable to Patterns of Idea Development
Using Grammatical Signals Suitable to Patterns of Idea DevelopmentUsing Grammatical Signals Suitable to Patterns of Idea Development
Using Grammatical Signals Suitable to Patterns of Idea Development
 
Expanded definition: technical and operational
Expanded definition: technical and operationalExpanded definition: technical and operational
Expanded definition: technical and operational
 
Reading and Writing Skills 11 quarter 4 melc 1
Reading and Writing Skills 11 quarter 4 melc 1Reading and Writing Skills 11 quarter 4 melc 1
Reading and Writing Skills 11 quarter 4 melc 1
 
Student Profile Sample - We help schools to connect the data they have, with ...
Student Profile Sample - We help schools to connect the data they have, with ...Student Profile Sample - We help schools to connect the data they have, with ...
Student Profile Sample - We help schools to connect the data they have, with ...
 
Decoding the Tweet _ Practical Criticism in the Age of Hashtag.pptx
Decoding the Tweet _ Practical Criticism in the Age of Hashtag.pptxDecoding the Tweet _ Practical Criticism in the Age of Hashtag.pptx
Decoding the Tweet _ Practical Criticism in the Age of Hashtag.pptx
 
How to Fix XML SyntaxError in Odoo the 17
How to Fix XML SyntaxError in Odoo the 17How to Fix XML SyntaxError in Odoo the 17
How to Fix XML SyntaxError in Odoo the 17
 
ICS2208 Lecture6 Notes for SL spaces.pdf
ICS2208 Lecture6 Notes for SL spaces.pdfICS2208 Lecture6 Notes for SL spaces.pdf
ICS2208 Lecture6 Notes for SL spaces.pdf
 
Narcotic and Non Narcotic Analgesic..pdf
Narcotic and Non Narcotic Analgesic..pdfNarcotic and Non Narcotic Analgesic..pdf
Narcotic and Non Narcotic Analgesic..pdf
 
INTRODUCTION TO CATHOLIC CHRISTOLOGY.pptx
INTRODUCTION TO CATHOLIC CHRISTOLOGY.pptxINTRODUCTION TO CATHOLIC CHRISTOLOGY.pptx
INTRODUCTION TO CATHOLIC CHRISTOLOGY.pptx
 
Beauty Amidst the Bytes_ Unearthing Unexpected Advantages of the Digital Wast...
Beauty Amidst the Bytes_ Unearthing Unexpected Advantages of the Digital Wast...Beauty Amidst the Bytes_ Unearthing Unexpected Advantages of the Digital Wast...
Beauty Amidst the Bytes_ Unearthing Unexpected Advantages of the Digital Wast...
 
Q-Factor HISPOL Quiz-6th April 2024, Quiz Club NITW
Q-Factor HISPOL Quiz-6th April 2024, Quiz Club NITWQ-Factor HISPOL Quiz-6th April 2024, Quiz Club NITW
Q-Factor HISPOL Quiz-6th April 2024, Quiz Club NITW
 

Red Flags Part II

  • 1. Lab Testing in Metabolic Disease: Spotting the Red Flags, Part II Mark Korson, MD VMP Genetics, LLC
  • 2. Disclosures MARK KORSON does not have anything to disclose.
  • 3. 1. Review how simple biochemical tests indicate important pathophysiologic scenarios. 2. Describe patterns of routine biochemical testing that can increase suspicion about an underlying metabolic disease 3. Recognize the uncommon physiological significance of certain chemistry tests OBJECTIVES © Copyright 2020. VMP Genetics. All rights reserved
  • 4. © Copyright 2019 VMP Genetics. All rights reserved Urinalysis - blood
  • 5. An otherwise healthy athletic teenager complains of his muscles aching after football work-outs. He says that his arms and shoulders feel less strong than they did during last year’s season. After one strenuous practice (a lot of tackling), he develops intense pain in his shoulders and upper arms and thighs. CASE #1
  • 6. Two hours later, he voids a painless “bloody” urine. Upon direct questioning, the color is more cola-colored than red blood. A urinalysis shows large blood and protein. Case 1
  • 7. • Think RENAL BLOOD ON A URINALYSIS © Copyright 2020. VMP Genetics. All rights reserved U/A – blood Micro - RBCs
  • 8. • Think RENAL BLOOD ON A URINALYSIS U/A – blood Micro - RBCs U/A – blood Micro – no RBCs Think… A. Heart B. Muscle C. Liver D. Bladder © Copyright 2020. VMP Genetics. All rights reserved
  • 9. • Think RENAL BLOOD ON A URINALYSIS U/A – blood Micro - RBCs U/A – blood Micro – no RBCs Think… A. Heart B. Muscle C. Liver D. Bladder © Copyright 2020. VMP Genetics. All rights reserved
  • 10. Two hours later, he voids a painless “bloody” urine. Upon direct questioning, the color is more cola-colored than red blood. A urinalysis shows large blood and protein. Diagnosis – carnitine palmitoyltransferase (CPT) II deficiency, a defect in fatty acid oxidation Case 1
  • 11. CARNITINE PALMITOYLTRANSFERASE (CPT) II DEF’Y • Muscles convert fat to energy during prolonged exercise Physiology © Copyright 2020. VMP Genetics. All rights reserved • With exercise: • Muscle pain, weakness • Myoglobinuria • Cardiomyopathy Symptoms
  • 12. SUMMARY POINT • Blood on a dipstick should be confirmed by checking for RBCs in a microscopic examination • If none are seen, it is not “blood” • Think myoglobin, not hemoglobin © Copyright 2020. VMP Genetics. All rights reserved
  • 13. © Copyright 2019 VMP Genetics. All rights reserved Transaminases (AST, ALT)
  • 14. Lab tests: • CBC: Hgb=13.3, WBC=10.5, Plts=238 • Lytes: Na=139, K=4.5, Cl=92, HCO3=29 • BUN=10.6, creatinine=8.8 • AST=4580 (NL=5-40), ALT=1200 (NL=5-40) • Bilirubin: Total=0.9, direct=0.1 • Alkaline phosphatase=140 (NL=44-147) Cairns AP, et al.Nephrol Dial Transpl.2000.
  • 15. Lab tests: • CBC: Hgb=13.3, WBC=10.5, Plts=238 • Lytes: Na=139, K=4.5, Cl=92, HCO3=29 • BUN=10.6, creatinine=8.8 • AST=4580 (NL=5-40), ALT=1200 (NL=5-40) • Bilirubin: Total=0.9, direct=0.1 • Alkaline phosphatase=140 (NL=44-147) Cairns AP, et al.Nephrol Dial Transpl.2000. Based on these lab data, which organ system worries you the most? A. Liver B. Kidneys C. Bone D. Heart E. Muscle
  • 16. Lab tests: • CBC: Hgb=13.3, WBC=10.5, Plts=238 • Lytes: Na=139, K=4.5, Cl=92, HCO3=29 • BUN=10.6, creatinine=8.8 • AST=4580 (NL=5-40), ALT=1200 (NL=5-40) • Bilirubin: Total=0.9, direct=0.1 • Alkaline phosphatase=140 (NL=44-147) Cairns AP, et al.Nephrol Dial Transpl.2000. Based on these lab data, which organ system worries you the most? A. Liver? B. Kidneys C. Bone D. Heart E. Muscle
  • 17. A 41 year old man experiences dark urine for three days, associated with extreme fatigue, pain and heaviness in his legs. The symptoms were triggered after a significant amount of heavy work while moving house the previous week. There is a history of similar symptoms following moderate exercise during the previous 20 years. CASE #2 Cairns AP, et al.Nephrol Dial Transpl.2000.
  • 18. Past medical history significant for two acute episodes of gout. On no medications. Ex-smoker (5 years). Drank ~10 units of alcohol per week. Examination: • HR=80/min, BP=160/82 • Normal muscle tone, power. Normal sensation. Normal reflexes. Cairns AP, et al.Nephrol Dial Transpl.2000. Case 2
  • 19. Lab tests: • CBC: Hgb=13.3, WBC=10.5, Plts=238 • Lytes: Na=139, K=4.5, Cl=92, HCO3=29 • BUN=10.6, creatinine=8.8 • AST=4580 (NL=5-40), ALT=1200 (NL=5-40) • Bilirubin: Total=0.9, direct=0.1 • Alkaline phosphatase=140 (NL=44-147) Cairns AP, et al.Nephrol Dial Transpl.2000. Case 2
  • 20. Lab tests: • CBC: Hgb=13.3, WBC=10.5, Plts=238 • Lytes: Na=139, K=4.5, Cl=92, HCO3=29 • BUN=10.6, creatinine=8.8 • AST=4580 (NL=5-40), ALT=1200 (NL=5-40) • Bilirubin: Total=0.9, direct=0.1 • Alkaline phosphatase=140 (NL=44-147) • CK=600 (NL=25-180) • Aldolase=22.2 (NL=1.2-7.6) Cairns AP, et al.Nephrol Dial Transpl.2000. Case 2
  • 21. Diagnosis: • Very long chain acyl CoA dehydrogenase (VLCAD) deficiency Cairns AP, et al.Nephrol Dial Transpl.2000. Case 2
  • 22. VERY LONG CHAIN ACYL CoA DEHYDROGENASE (VLCAD) DEF’Y • A defect in fatty acid oxidation (conversion of fat to ketones) VLCAD def’y © Copyright 2020. VMP Genetics. All rights reserved • The liver converts fat to ketones during fasting or poor calorie intake • Muscles convert fat to energy during prolonged exercise Physiology
  • 23. VERY LONG CHAIN ACYL CoA DEHYDROGENASE (VLCAD) DEF’Y • Reduced fasting tolerance • Hypoglycemia, altered mental status with prolonged fasting/poor fat intake • With exercise: • Muscle pain, weakness • Myoglobinuria • Cardiomyopathy Symptoms © Copyright 2020. VMP Genetics. All rights reserved
  • 24. TRANSAMINASES • Indicators of hepatocyte integrity • If abNL, may reflect hepatoxicity • Abnormal in many (metabolic) diseases Significance © Copyright 2020. VMP Genetics. All rights reserved
  • 25. TRANSAMINASES • Indicators of hepatocyte integrity • If abNL, may reflect hepatoxicity • Abnormal in many (metabolic) diseases Significance • Concentrated in the liver but are also found in: • Skeletal muscle • Myocardium • Kidney Not necessarily liver-specific © Copyright 2020. VMP Genetics. All rights reserved
  • 26. A neonate is admitted to the NICU on day 3 of life in severe congestive heart failure. On examination, he is non-dysmorphic and lethargic. Weight=2.2 kg. Echocardiogram identifies a dilated cardiomyopathy with an ejection fraction of 20%. CASE #3 Courtesy SIMD-NAMA 2019
  • 27. Lab findings: • Venous gas: pH=7.2, HCO3=17 • Glucose=25 • AST=230, ALT=200 • CK>500 Metabolic testing – VLCAD deficiency (a defect in long chain fatty acid oxidation) Courtesy SIMD-NAMA 2019 Case 3
  • 28. A newborn is born at term to consanguineous parents. Apgar score: 91 and 105. Weight=2.93 kg. On day 2, he developed lethargy and apathy. Katz.MolecGeneticsMetabolism.2017 Lab findings: • Glucose=normal • AST=240, ALT=58 • CK=13,445 CASE #4
  • 29. He later developed left ventricular hypertrophy and a pericardial effusion. Metabolic testing – VLCAD deficiency Katz.MolecGeneticsMetabolism.2017 Case 4
  • 30. SUMMARY POINT • When AST and ALT are high, look carefully at other markers of liver disease. • If AST and ALT are the only ones elevated, and/or if there are concerns about muscle symptoms, order a CK © Copyright 2020. VMP Genetics. All rights reserved
  • 31. © Copyright 2019 VMP Genetics. All rights reserved Bilirubin
  • 32. CASE #5 A female is born to consanguineous parents (first cousins) at term following an unremarkable pregnancy. Normal Apgar scores. Birth weight=3300 gm. Develops jaundice on day 2 and starts having feeding problems. Admitted to hospital on day 3 because of fever and jaundice. On examination, she is lethargic and has a weak suck. Kundak.Turk J Hemat.2012
  • 33. Lab tests: • CBC: Hgb=15.7, WBC=10.3, Plts=233 • Electrolytes: Na=147, K=4.5 • Total bilirubin=15.6, direct=1.0 • AST=1367, ALT=504 Kundak.Turk J Hemat.2012 Case 5
  • 34. Lab tests: • CBC: Hgb=15.7, WBC=10.3, Plts=233 • Electrolytes: Na=147, K=4.5 • Total bilirubin=15.6, direct=1.0 • AST=1367, ALT=504 Kundak.Turk J Hemat.2012 Case 5 Based on the nature of the hyperbilirubinemia, this baby is not likely to have galactosemia. A. True B. False
  • 35. Lab tests: • CBC: Hgb=15.7, WBC=10.3, Plts=233 • Electrolytes: Na=147, K=4.5 • Total bilirubin=15.6, direct=1.0 • AST=1367, ALT=504 Kundak.Turk J Hemat.2012 Case 5 Based on the nature of the hyperbilirubinemia, this baby is not likely to have galactosemia. A. True B. False
  • 36. …causes a direct hyperbilirubinemia” “Metabolic liver disease… ASSESSMENT OF LIVER DISEASE / DYSFUNCTION
  • 37. • …causes a direct hyperbilirubinemia” “Metabolic liver disease… ASSESSMENT OF LIVER DISEASE / DYSFUNCTION • True but it starts as an unconjugated hyperbilirubinemia © Copyright 2020. VMP Genetics. All rights reserved
  • 38. Age (days of life) Direct/ Total Bilirubin Ratio 0 4 102 8 0.2 0.4 0.6 0.8 1.0 Galactosemia: Direct / Total Bilirubin (n=27)
  • 39. Lab tests: • CBC: Hgb=15.7, WBC=10.3, Plts=233 • Electrolytes: Na=147, K=4.5 • Total bilirubin=15.6, direct=1.0 • AST=1367, ALT=504 • Urine reducing substances positive Confirmation – Galactose-1-phosphate uridyltransferase low Diagnosis - galactosemia Kundak.Turk J Hemat.2012 Case 5
  • 40. SUMMARY POINT • Don’t rule out a metabolic disease just because the patient presents with primarily an unconjugated hyperbilirubinemia… © Copyright 2020. VMP Genetics. All rights reserved
  • 41. GALACTOSEMIA • A defect in metabolizing galactose, a component of milk sugar (lactose) GALT def’y © Copyright 2020. VMP Genetics. All rights reserved • Poor feeding, failure to thrive • Liver disease  failure • Cataracts • Sepsis risk in the newborn period Symptoms
  • 42. There is a concern for a diagnosis of galactosemia. Cow’s milk feedings are held. Which ONE of the following actions would be your next move? A. Molecular DNA testing to confirm the diagnosis B. Complete sepsis work-up C. Eye examination for cataracts D. Assess for coagulopathy CASE #6 © Copyright 2020. VMP Genetics. All rights reserved
  • 43. There is a concern for a diagnosis of galactosemia. Cow’s milk feedings are held. Which ONE of the following actions would be your next move? A. Molecular DNA testing to confirm the diagnosis B. Complete sepsis work-up C. Eye examination for cataracts D. Assess for coagulopathy © Copyright 2020. VMP Genetics. All rights reserved Case 6
  • 44. Lab tests: • CBC: Hgb=15.7, WBC=10.3, Plts=233 • Electrolytes: Na=147, K=4.5 • Total bilirubin=15.6, direct=1.0 • AST=1367, ALT=504 • Urine reducing substances positive • PT>60 sec; INR>6; aPTT=88 sec Diagnosis – classical galactosemia Kundak.Turk J Hemat.2012 Case 6
  • 45. COAGULATION MEASUREMENTS • An important indicator of hepatic synthetic function Significance • Transaminase and bilirubin levels do not predict and do not correlate with PT, INR, PTT Caution! © Copyright 2020. VMP Genetics. All rights reserved
  • 46. A male infant presents with lethargy. His belly is distended due to ascites and his liver edge is irregular and firm at 5 cm below the right costal margin. • AST=65 • Bilirubin: total=2.1, direct=0.99 • PT=26.8 sec, INR=61.1 sec Case #7 - TYROSINEMIA TYPE I Rashad.SudJPediatr.2011
  • 47. REMINDER • When assessing a patient for possible metabolic liver disease, always assess all aspects of liver function. © Copyright 2020. VMP Genetics. All rights reserved
  • 48. • AST, ALT • Alkaline phosphatase (5’-nucleotidase and GGTP) • Bilirubin, total and direct • PT, INR, PTT • Albumin Tests ASSESSMENT OF LIVER DISEASE / DYSFUNCTION © Copyright 2020. VMP Genetics. All rights reserved
  • 49. • AST, ALT • Alkaline phosphatase (5’-nucleotidase and GGTP) • Bilirubin, total and direct • PT, INR, PTT • Albumin • ⍺-fetoprotein • Glucose, NH3 Tests ASSESSMENT OF LIVER DISEASE / DYSFUNCTION © Copyright 2020. VMP Genetics. All rights reserved
  • 50. © Copyright 2019 VMP Genetics. All rights reserved The anion gap (electrolytes) Urinalysis - pH
  • 51. What is the most common cause of a metabolic acidosis? © Copyright 2020. VMP Genetics. All rights reserved
  • 52. PRIMARY METABOLIC ACIDOSIS INCREASED ANION GAP NORMAL ANION GAP - GI disease © Copyright 2020. VMP Genetics. All rights reserved
  • 53. PRIMARY METABOLIC ACIDOSIS INCREASED ANION GAP NORMAL ANION GAP - GI disease - Renal disease - Metabolic disease © Copyright 2020. VMP Genetics. All rights reserved
  • 54. PRIMARY METABOLIC ACIDOSIS INCREASED ANION GAP NORMAL ANION GAP - GI disease - Renal disease - Metabolic disease - Shock, dehydration - Starvation - Poisons, toxins - Metabolic disease © Copyright 2020. VMP Genetics. All rights reserved
  • 55. PRIMARY METABOLIC ACIDOSIS INCREASED ANION GAPINCREASED ANION GAP - Shock, dehydration - Starvation - Poisons, toxins - Metabolic disease ORGANIC ACIDEMIAS CONGENITAL LACTIC ACIDEMIAS © Copyright 2020. VMP Genetics. All rights reserved
  • 56. PRIMARY METABOLIC ACIDOSIS NORMAL ANION GAP - GI disease - Renal disease - Metabolic disease METABOLIC LIVER DISEASE MITOCHONDRIAL DISEASE CYSTINOSIS © Copyright 2020. VMP Genetics. All rights reserved
  • 57. THE “ANION GAP” There is no “anion gap” really… © Copyright 2020. VMP Genetics. All rights reserved
  • 58. THE ANION GAP • Difference between measured anions and cations in the blood Definition Calculation • Anion gap = Na - (Cl + HCO3) • Anion gap = 140 - (105 + 25) • Anion gap = 10 • Normal anion gap = 10-15 © Copyright 2020. VMP Genetics. All rights reserved
  • 59. THE NON-ANION GAP ACIDOSIS Anion gap = Na - (Cl + HCO3) Anion gap = 140 - (115 + 10) Anion gap = 15 HIGH NORMAL LOW  Bicarbonate loss (urine or stool) © Copyright 2020. VMP Genetics. All rights reserved
  • 60. THE ANION GAP ACIDOSIS Anion gap = Na - (Cl + HCO3) Anion gap = 140 - (105 + 10) Anion gap = 25 NORMAL HIGH LOW  Anion accumulation © Copyright 2020. VMP Genetics. All rights reserved
  • 61. THE ANION GAP ACIDOSIS Anion gap = Na - (Cl + HCO3) Anion gap = 140 - (105 + 10) Anion gap = 25  Anion accumulation (lactate, ketones, organic acids, toxins…) NORMAL HIGH LOW © Copyright 2020. VMP Genetics. All rights reserved
  • 62. A 6 month old infant male, product of a healthy pregnancy/labor/delivery, is found to have a distended belly at 3 months. By that time, he has lost 1 kg of weight and is failing to thrive. He continues to feed every 3-4 hours day and night. At 5 months of age, the liver is noted to be enlarged. He is evaluated in the ED shortly after that for fever and upper respiratory symptoms. He presents to the ED, looking ill. Last feeding ~3 hours prior to arrival. CASE #8 © Copyright 2020. VMP Genetics. All rights reserved
  • 63. Lab tests: • Glucose=39 mg/dL • Electrolytes: Na=141, K=3.7, Cl=112, HCO3=15 • ALT=118, AST=274 • Other liver functions normal • Lactate=3.6 mmol/L (NL<2.2) • Urinalysis: pH=6.5 © Copyright 2020. VMP Genetics. All rights reserved Case 8
  • 64. Lab tests: • Glucose=39 mg/dL • Electrolytes: Na=141, K=3.7, Cl=112, HCO3=15 • ALT=118, AST=274 • Other liver functions normal • Lactate=3.6 mmol/L (NL<2.2) • Urinalysis: pH=6.5 © Copyright 2020. VMP Genetics. All rights reserved Anion gap = 14 (NL) Case 8
  • 65. Lab tests: • Glucose=39 mg/dL • Electrolytes: Na=141, K=3.7, Cl=112, HCO3=15 • ALT=118, AST=274 • Other liver functions normal • Lactate=3.6 mmol/L (NL<2.2) • Urinalysis: pH=6.5 Based on these clinical/lab data, this patient has liver disease. Which other organ are you worried about? A. Brain B. Kidneys C. Eyes D. Heart E. Muscle © Copyright 2020. VMP Genetics. All rights reserved Case 8
  • 66. Lab tests: • Glucose=39 mg/dL • Electrolytes: Na=141, K=3.7, Cl=112, HCO3=15 • ALT=118, AST=274 • Other liver functions normal • Lactate=3.6 mmol/L (NL<2.2) • Urinalysis: pH=6.5 Based on these clinical/lab data, this patient has liver disease. Which other organ are you worried about? A. Brain B. Kidneys C. Eyes D. Heart E. Muscle © Copyright 2020. VMP Genetics. All rights reserved Case 8
  • 67. Lab tests: • Glucose=39 mg/dL • Electrolytes: Na=141, K=3.7, Cl=112, HCO3=15 • ALT=118, AST=274 • Other liver functions normal • Lactate=3.6 mmol/L (NL<2.2) • Urinalysis: pH=6.5 Diagnosis – glycogen storage disease type I Based on these clinical/lab data, this patient has liver disease. Which other organ are you worried about? A. Brain B. Kidneys C. Eyes D. Heart E. Muscle © Copyright 2020. VMP Genetics. All rights reserved Case 8
  • 68. © Copyright 2019 VMP Genetics. All rights reserved Glucose + Ketones
  • 69. Three glucose-ketone scenarios: A. The septic newborn: • Blood glucose=32 mg/dL • Urine ketones=trace B. The 3 month old child with gastroenteritis and dehydration: • Blood glucose=40 mg/dL • Urine ketones=1+ C. The septic newborn: • Blood glucose=32 mg/dL • Urine ketones=4+ CASE #9 © Copyright 2020. VMP Genetics. All rights reserved All are abnormal clinical situations but which of the glucose-ketone relationships are pathological? A. A, B, C B. A, B C. B, C D. A, C E. A
  • 70. HYPOKETOTIC HYPOGLYCEMIA © Copyright 2020. VMP Genetics. All rights reserved
  • 71. HYPOKETOTIC HYPOGLYCEMIA HIGH Insulin State LOW Insulin State © Copyright 2020. VMP Genetics. All rights reserved
  • 72. HYPOKETOTIC HYPOGLYCEMIA HIGH Insulin State FAT FATTY ACIDS KETONES © Copyright 2020. VMP Genetics. All rights reserved
  • 73. HYPOKETOTIC HYPOGLYCEMIA HIGH Insulin State • Insulin tumor • Infant of DM mother • Beckwith-Wiedemann syndrome • Iatrogenic © Copyright 2020. VMP Genetics. All rights reserved
  • 74. HYPOKETOTIC HYPOGLYCEMIA FAT FATTY ACIDS KETONES LOW Insulin State © Copyright 2020. VMP Genetics. All rights reserved
  • 75. HYPOKETOTIC HYPOGLYCEMIA LOW Insulin State • Fatty acid oxidation defects • Glycogen storage disease type I © Copyright 2020. VMP Genetics. All rights reserved
  • 76. • Immaturity in fatty acid oxidation  reduced production • Rapid metabolic rates  increased consumption/uptake • …hypoketotic hypoglycemia is normal In neonates… WHAT’S THE STORY WITH NEONATAL KETOGENESIS? © Copyright 2020. VMP Genetics. All rights reserved
  • 77. • Hypoketosis is normal • Significant ketosis is not normal • Absent or inadequate ketosis is never normal in a very catabolic or hypoglycemic child In neonates… KETONES – “THE RULES” Beyond 2-3 months of age… © Copyright 2020. VMP Genetics. All rights reserved
  • 78. Three glucose-ketone scenarios: A. The septic newborn: • Blood glucose=32 mg/dL • Urine ketones=trace B. The 3 month old child with gastroenteritis and dehydration: • Blood glucose=40 mg/dL • Urine ketones=1+ C. The septic newborn: • Blood glucose=32 mg/dL • Urine ketones=4+ CASE #9 © Copyright 2020. VMP Genetics. All rights reserved All are abnormal clinical situations but which of the glucose-ketone relationships are pathological? A. A, B, C B. A, B C. B, C D. A, C E. A
  • 79. Three glucose-ketone scenarios: A. The septic newborn: • Blood glucose=32 mg/dL • Urine ketones=trace B. The 3 month old child with gastroenteritis and dehydration: • Blood glucose=40 mg/dL • Urine ketones=1+ C. The septic newborn: • Blood glucose=32 mg/dL • Urine ketones=4+ CASE #9 © Copyright 2020. VMP Genetics. All rights reserved All are abnormal clinical situations but which of the glucose-ketone relationships are pathological? A. A, B, C B. A, B C. B, C D. A, C E. A
  • 80. Questions? Call Genetics! We like answering your questions! THANK YOU FOR PARTICIPATING TODAY.

Editor's Notes

  1. Read the case out loud. Comment along the way, as appropriate.
  2. Read the data out loud. Comment along the way, as appropriate.
  3. Read the data out loud. Comment along the way, as appropriate.
  4. Read the data out loud. Comment along the way, as appropriate.
  5. A follow-up study of 27 patients with classic galactosemia identified through the New England Newborn Screening Program between 1975 and 1989. Most patients had issues with jaundice, and all available total and direct bilirubin levels from their charts are included. The bilirubin is mostly unconjugated throughout the first 10 days (the end of the period being reviewed), though the average direct fraction exceeds 10% of the total bilirubin by Day 4 of life and 20% by Day 8.
  6. Read the data out loud. Comment along the way, as appropriate.
  7. Show the polling results. Comment on the polling stats if you wish. It is well known that untreated galactosemia in the newborn period carries a (~25%) risk of gram-negative sepsis (especially E. coli) due to impaired bactericidal activity from accumulation of galactose metabolites. It is also well-known that galactosemia can be associated with a significant coagulopathy. Therefore it is important to consider sepsis in a galactosemic newborn who is clinically unwell. However, how comfortable will you be to insert a LP needle into the spinal column in a patient with a severe coagulopathy? Do you need to address the coagulopathy first?
  8. And lo and behold, this patient’s coagulation studies are way out of whack.
  9. An important red flag. Review the slide information, and comment as appropriate.
  10. Alkaline phosphatase – Most of us think of alkaline phosphatase as typically elevated in association with cholestasis or biliary disease 5’-nucleotidase and GGTP are similar and can be elevated in cholestatic liver disease but not in non-liver causes, so is helpful in differentiating the source of an elevated alkaline phosphatase. Some (Hoffman, Zschocke) would also include LDH (not specific), cholinesterase (excellent biomarker for cirrhosis); not included here.
  11. Diarrhea… due to the loss of bicarbonate from the gut. Renal tubular disease also results in a loss of bicarbonate Chloride levels rise causing a hyperchloremic metabolic acidosis… and the anion gap is preserved.
  12. Metabolic disorders can be associated with a normal anion gap especially when part of the pathology involves renal tubular dysfunction, as in a renal Fanconi syndrome associated with metabolic liver disease, or the renal tubular disease of cystinosis or sometimes when mitochondrial disease involves the kidney.
  13. An increased anion gap is more what we typically think about in a sick patient who is very dehydrated and shocky (hence a high lactate) or starving (with high ketones). Poisons and toxins can raise the anion gap as well. And certainly metabolites, whether toxic or not, can raise the anion gap… lactate and ketones (neither is toxic), or methylmalonate and 3-hydroxypropionate (both toxic), or a combination of them in a very sick patient. Remember that a difficult blood draw that results in significant hemolysis can raise the lactate in the blood draw. Red cells have no mitochondria; they are exclusively anaerobic, and with hemolysis, the RBCs release their lactate, altering the acid-base state in the blood specimen.
  14. Where metabolic disease is concerned, statistically, look at metabolic acidosis with an increased anion gap. These are usually disorders of intoxication or disorders of energy metabolism, and many of them are treatable.
  15. Now this case is not a newborn case but the principle is important so we are presenting it here. Read the case out loud. Comment along the way, as appropriate.
  16. Read the data aloud, as appropriate.
  17. Read the data aloud, as appropriate.
  18. Read the question. Leave 30-45 seconds for the attendees to answer. However, if the response rate is slow and if you can see the number of participants submitting answers in the Zoom window, once more than 1/2 - 2/3 of those attending submit an answer, you can close the polling.
  19. Show the polling results. Comment on the polling stats if you wish. The low blood bicarbonate level nis highlighted. In such a situation, the kidneys should be reabsorbing as much bicarbonate as possible from the urine, thereby acidifying the urine. However, in this case, the urine pH is somewhat alkalotic at 6.5, suggesting some renal tubular dysfunction. This could be part of a larger renal Fanconi syndrome that is characteristic of some metabolic liver diseases.
  20. And this is a case of glycogen storage disease type I. When the liver disease becomes established, the renal tubular dysfunction begins to set in. A red flag.
  21. 17
  22. 17
  23. 17
  24. 17
  25. 17
  26. 17
  27. Since ketoacidosis is rare in a neonate, the presence of ketosis in a neonate should ALWAYS prompt concern for an organic acidemia. Also persistent ketosis not amenable to standard therapies should prompt concern at any age. But in a older child, an absence of appropriate ketosis in the presence of hypoglycemia or an energy deficiency state should also prompt concern. So, sometimes a “normal’ urinalysis shouldn’t be normal at all – after the neonatal period there should be ketones in it if the child is fasted!